Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CUE

Cue Biopharma Inc

Jun 10 • 01:50PM ET

30.32

-0.12 -0.41 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN EDSA GNLX KZIA PYXS VRCA VTVT GALT IMUX SPRO

| Held by: VTI VXF DFAS AVSC DFAU DFMC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.53	Insider Own	10.63%	Shs Outstand	4.20M	Perf Week	12.65%
Market Cap	127.33M	Forward P/E	-	EPS next Y	-9.45	Insider Trans	264.04%	Shs Float	3.75M	Perf Month	-3.21%
Enterprise Value	114.39M	PEG	-	EPS next Q	-1.69	Inst Own	16.98%	Short Float	7.41%	Perf Quarter	211.02%
Income	-19.52M	P/S	3.89	EPS this Y	20.95%	Inst Trans	-1.15%	Short Ratio	0.37	Perf Half Y	91.27%
Sales	32.73M	P/B	4.57	EPS next Y	-42.32%	ROA	-73.49%	Short Interest	0.28M	Perf YTD	230.88%
Book/sh	6.64	P/C	7.77	EPS next 5Y	-	ROE	-138.52%	52W High	41.42 -26.81%	Perf Year	59.49%
Cash/sh	3.90	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-83.13%	52W Low	4.97 509.84%	Perf 3Y	-72.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	99.01%	Volatility	15.99% 14.29%	Perf 5Y	-92.50%
Dividend TTM	-	EV/Sales	3.50	EPS Y/Y TTM	72.33%	Oper. Margin	-59.83%	ATR (14)	3.95	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.57	Sales Y/Y TTM	309.60%	Profit Margin	-59.65%	RSI (14)	62.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.57	EPS Q/Q	78.25%	SMA20	22.48%	Beta	2.41	Target Price	115.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1250.59%	SMA50	43.26%	Rel Volume	0.03	Prev Close	30.44
Employees	29	LT Debt/Eq	0.09	Earnings	May 14 AMC	SMA200	79.17%	Avg Volume	745.71K	Price	30.32
IPO	Jan 02, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	14,764	Change	-0.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)